Tea tree oil as a novel antipsoriasis weapon

Skin Pharmacology and Physiology

Volumn 25, Issue 3, 2012, Pages 162-163

  Pazyar, Nader ^a   Yaghoobi, Reza ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Melaleuca alternifolia; Psoriasis; Tea tree oil

Indexed keywords

CORTICOSTEROID; INTERLEUKIN 1; INTERLEUKIN 8; PROSTAGLANDIN E2; TEA TREE OIL; TERPINEN 4 OL; TUMOR NECROSIS FACTOR ALPHA;

ACNE VULGARIS; ARTICLE; AUSTRALIA; BIOSYNTHESIS; CELL ACTIVATION; DRUG EFFECT; EXTRAVASATION; HUMAN; IMMUNOPATHOGENESIS; KERATINOCYTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIASIS; T LYMPHOCYTE; TISSUE METABOLISM; VASODILATATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DERMATOLOGIC AGENTS; HUMANS; INFLAMMATION MEDIATORS; PSORIASIS; SKIN; TEA TREE OIL; VASODILATION;

EID: 84859141695     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000337936     Document Type: Article

References (15)

1. Bari L, Bacsa S, Sonkoly E, Bata-Csörgo Z, Kemény L, Dobozy A, Széll M: Comparison of stress-induced PRINS gene expression in normal human keratinocytes and HaCaT cells. Arch Dermatol Res 2011; 303: 745-752
2. Ghiasi M, Nouri M, Abbasi A, Hatami P, Abbasi MA, Nourijelyani K: Psoriasis and increased prevalence of hypertension and diabetes mellitus. Indian J Dermatol 2011; 56: 533-536
3. Montesu M, Addis G, Satta R, Cottoni F: Adverse reactions during biological drug therapy in psoriasis: clinical series and a review of the literature. G Ital Dermatol Venereol 2011; 146: 273-281
4. Balato A, Lembo S, Cirillo T, Megna M, Raimondo A, Di Costanzo L: Anti-tumor necrosis factor-therapy in the management of psoriasis and B-chronic lymphocytic leukemia. Case Rep Dermatol 2011; 3: 60-63
5. Renne J, Schäfer V, Werfel T, Wittmann M: Interleukin-1 from epithelial cells fosters T cell-dependent skin inflammation. Br J Dermatol 2010; 162: 1198-2205
6. Ferran M, Ferran M, Galván AB, Giménez- Arnau A, Giménez-Arnau A, Pujol RM, Pujol RM, Santamarïa-Babi LF, Santamarïa- Babi LF: Production of interleukin-8 by circulating CLA+ T cells with skin tropism in patients with psoriasis and in healthy controls. Actas Dermosifiliogr 2010; 101: 151-155
7. Michel B, Chantreuil J, Guilhou JJ, Crastes de Paulet A, Meynadier J: Prostaglandin biosynthesis in psoriatic epidermis (author's transl). Ann Dermatol Venereol 1980; 107: 889-893 (Pubitemid 11169513)
8. Hern S, Stanton AW, Mellor R, Levick JR, Mortimer PS: Control of cutaneous blood vessels in psoriatic plaques. J Invest Dermatol 1999; 113: 127-132 (Pubitemid 29328171)
9. Carson CF, Riley TV: Safety, efficacy and provenance of tea tree (Melaleuca alternifolia) oil. Contact Dermatitis 2001; 45: 65-67 (Pubitemid 32738421)
10. Mondello F, De Bernardis F, Girolam A, Cassone A, Salvatore G: In vivo activity of terpinen- 4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species. BMC Infect Dis 2006; 6: 158
11. Carson CF, Hammer KA, Riley TV: Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev 2006; 19: 50-62 (Pubitemid 43158450)
12. Martin KW, Ernst E: Herbal medicines for treatment of bacterial infections: a review of controlled clinical trials. J Antimicrob Chemother 2003; 51: 241-246 (Pubitemid 36231142)
13. Enshaieh S, Jooya A, Siadat AH, Iraji F: The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study. Indian J Dermatol Venereol Leprol 2007; 73: 22-25 (Pubitemid 46347991)
14. Bakker CV, Blömeke B, Coenraads PJ, Schuttelaar ML: Ascaridole, a sensitizing component of tea tree oil, patch tested at 1% and 5% in two series of patients. Contact Dermatitis 2011; 65: 240-241
15. Khokhra S, Diwan A: Microemulsion based transdermal drug delivery of tea tree oil. Int J Drug Dev Res 2011; 3: 191-198